According to a study by scientists from Osaka University (Japan), metabolic syndrome (obesity, diabetes, insulin resistance and metabolic disorders) is associated with a high risk of developing pancreatic cancer. Research results published In EClinical Medicine.
Data obtained from 4,600,443 people with health insurance in Japan were used in the research. Information provided by the Japanese Medical Data Center. The scientists analyzed data on the subjects’ health status, family history and prescribed medical treatment. Researchers also identified factors that affect the incidence of pancreatic cancer.
During the 41-month follow-up period, 87,857 people developed pancreatic cancer. It turns out that people suffering from metabolic syndrome (MS) are diagnosed with this disease more often. In Japan, metabolic syndrome criteria require a woman’s waist circumference to be more than 85 centimeters. The maximum allowed for men is 90 centimeters. Additionally, a person with metabolic syndrome must have low levels of high-density lipoprotein (HDL) in their blood, high blood pressure, and high fasting glucose levels.
Researchers stated that MS treatment may be an option to prevent the development of pancreatic cancer.
It was like that before was created A unique mobile application for weight loss.